Pages Menu
Twitter
Categories Menu

Posted by on Oct 8, 2009 in Infectious diseases

H1N1 Vaccine Table

H1N1 Vaccine Table

A simplified table of the FDA-approved vaccines against the 2009 H1N1 virus is provided here, with a focus on age and dose recommendations. For complete data, see this week’s MMWR.

Age

Formulation(s) Available 
(Manufacturer[s])

Dose, mL

No. Doses

6-23 mos

IM injection
(sanofi pasteur; CSL*)

0.25

2

24-35 mos

IM injection
(sanofi pasteur; CSL*)

0.25

2

Nasal spray
(MedImmune)

0.2

2

36-47 mos

IM injection
(sanofi pasteur; CSL*)

0.5

2

Nasal spray
(MedImmune)

0.2

2

4-9 y

IM injection
(sanofi pasteur; Novartis; CSL*)

0.5

2

Nasal spray
(MedImmune)

0.2

2

10-17 y

IM injection
(sanofi pasteur; Novartis; CSL*)

0.5

1

Nasal spray
(MedImmune)

0.2

1

18-49 y

IM injection
(sanofi pasteur; Novartis; CSL)

0.5

1

Nasal spray
(MedImmune)

0.2

1

>49 y

IM injection
(sanofi pasteur; Novartis; CSL)

0.5

1

The IM shots contain inactivated virus, and the nasal spray (from MedImmune) contains attenuated virus. Prefilled syringes do not contain mercury (that is, 25 microg Hg per 0.5 mL of vaccine, in the form of thimerosal preservative). When 2 doses are recommended, they are administered approximately 4 weeks apart.

The nasal spray vaccine is indicated for healthy, nonpregnant persons aged 2-49 years and should not be administered to persons with asthma. The dose of the nasal spray is divided equally between each nostril.  

Note: These data are for informational purposes only and should be confirmed by referring to authoritative sources (eg, the CDC) and/or a treating healthcare professional.

* Latter approved by FDA for age group on 11/12/09.

bmartin (1130 Posts)

A native East Tennessean, Barbara Martin is a formerly practicing, board-certified neurologist who received her BS (psychology, summa cum laude) and MD from Duke University before completing her postgraduate training (internship, residency, fellowship) at the Hospital of the University of Pennsylvania in Philadelphia. She has worked in academia, private practice, medical publishing, drug market research, and continuing medical education (CME). For the last 3 years, she has worked in a freelance capacity as a medical writer, analyst, and consultant. Follow Dr. Barbara Martin on and Twitter.